Payment overview · 2025
General Payments
$253.59
7 reported records · 4 companies
Healthcare provider profile · identity verified
John A Williams, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · NASHVILLE, TN · NPI 1538103692
Verified facts
What the public records show
CMS Open Payments records show John A Williams, M.D. received $253.59 in general payments during 2025 across 7 reported records.
ABBVIE INC. accounted for 46.6% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported CREON as an associated drug or biological on 91561 records involving 20616 distinct recipient NPIs. Public Medicare Part D data also shows 43 claims for Creon by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 16 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 61 claims for Synthroid by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported VRAYLAR as an associated drug or biological on 377741 records involving 62704 distinct recipient NPIs. Public Medicare Part D data also shows 16 claims for Vraylar by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Fiasp as an associated drug or biological on 15 records involving 15 distinct recipient NPIs. Public Medicare Part D data also shows 11 claims for Fiasp by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 99 claims for Ozempic by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Rybelsus as an associated drug or biological on 161257 records involving 55409 distinct recipient NPIs. Public Medicare Part D data also shows 20 claims for Rybelsus by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ABBVIE INC. | Unresolved — no canonical attribution shown | $118.07 | 46.6% | 1 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $48.06 | 18.9% | 2 | 2025 |
| Hologic Sales and Service, LLC | Unresolved — no canonical attribution shown | $46.45 | 18.3% | 2 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $41.01 | 16.2% | 2 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $253.59 | 7 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| QULIPTA Normalized: qulipta |
Drug | ABBVIE INC. | $118.07 | 1 | 2025 |
Source payment records
|
|||||
| Wegovy Normalized: wegovy |
Drug | Novo Nordisk Inc | $48.06 | 2 | 2025 |
Source payment records
|
|||||
| APTIMA Normalized: aptima |
Device | Hologic Sales and Service, LLC | $46.45 | 2 | 2025 |
Source payment records
|
|||||
| FREESTYLE LIBRE 3 Normalized: freestyle libre 3 |
Device | Abbott Laboratories | $41.01 | 2 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | CREON open payments reported associated product |
CMS Open Payments — General Payments 91561 supporting records · 20616 recipient NPIs · example record 1201352608 |
Creon · 2024 Exact normalized brand match · 1 Part D row |
43 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
16 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
61 | 18 |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | VRAYLAR open payments reported associated product |
CMS Open Payments — General Payments 377741 supporting records · 62704 recipient NPIs · example record 1201352550 |
Vraylar · 2024 Exact normalized brand match · 1 Part D row |
16 | suppressed by CMS |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Fiasp open payments reported associated product |
CMS Open Payments — General Payments 15 supporting records · 15 recipient NPIs · example record 1188262936 |
Fiasp · 2024 Exact normalized brand match · 1 Part D row |
11 | suppressed by CMS |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
99 | 33 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Rybelsus open payments reported associated product |
CMS Open Payments — General Payments 161257 supporting records · 55409 recipient NPIs · example record 1188130076 |
Rybelsus · 2024 Exact normalized brand match · 1 Part D row |
20 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1933 | 452 |
| Amlodipine Besylate | Amlodipine Besylate | 1246 | 315 |
| Eliquis | Apixaban | 938 | 113 |
| Levothyroxine Sodium | Levothyroxine Sodium | 889 | 195 |
| Furosemide | Furosemide | 766 | 209 |
| Lisinopril | Lisinopril | 729 | 179 |
| Tamsulosin Hcl | Tamsulosin Hcl | 649 | 158 |
| Losartan Potassium | Losartan Potassium | 637 | 163 |
| Trazodone Hcl | Trazodone Hcl | 620 | 149 |
| Metformin Hcl | Metformin Hcl | 595 | 162 |
| Metoprolol Tartrate | Metoprolol Tartrate | 595 | 138 |
| Omeprazole | Omeprazole | 589 | 162 |
| Sertraline Hcl | Sertraline Hcl | 572 | 107 |
| Hydrochlorothiazide | Hydrochlorothiazide | 563 | 151 |
| Mirtazapine | Mirtazapine | 528 | 137 |
| Potassium Chloride | Potassium Chloride | 522 | 143 |
| Clopidogrel | Clopidogrel Bisulfate | 464 | 105 |
| Gabapentin | Gabapentin | 439 | 106 |
| Carvedilol | Carvedilol | 427 | 100 |
| Levetiracetam | Levetiracetam | 381 | 55 |
| Metoprolol Succinate | Metoprolol Succinate | 368 | 106 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 364 | 118 |
| Simvastatin | Simvastatin | 335 | 84 |
| Alprazolam | Alprazolam | 334 | 55 |
| Meloxicam | Meloxicam | 332 | 90 |
| Duloxetine Hcl | Duloxetine Hcl | 319 | 66 |
| Hydralazine Hcl | Hydralazine Hcl | 318 | 73 |
| Escitalopram Oxalate | Escitalopram Oxalate | 303 | 71 |
| Donepezil Hcl | Donepezil Hcl | 300 | 54 |
| Pantoprazole Sodium | Pantoprazole Sodium | 287 | 88 |
| Allopurinol | Allopurinol | 273 | 66 |
| Nifedipine Er | Nifedipine | 262 | 65 |
| Buspirone Hcl | Buspirone Hcl | 261 | 52 |
| Baclofen | Baclofen | 249 | 36 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 249 | 49 |
| Xarelto | Rivaroxaban | 238 | 30 |
| Tizanidine Hcl | Tizanidine Hcl | 221 | 43 |
| Fluticasone Propionate | Fluticasone Propionate | 208 | 70 |
| Montelukast Sodium | Montelukast Sodium | 199 | 54 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 195 | 60 |
| Azithromycin | Azithromycin | 191 | 151 |
| Divalproex Sodium | Divalproex Sodium | 173 | 33 |
| Farxiga | Dapagliflozin Propanediol | 173 | 24 |
| Trulicity | Dulaglutide | 173 | 24 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 170 | 50 |
| Memantine Hcl | Memantine Hcl | 159 | 28 |
| Enulose | Lactulose | 157 | 25 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 157 | 51 |
| Risperidone | Risperidone | 152 | 23 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 149 | 49 |
| Methylprednisolone | Methylprednisolone | 148 | 125 |
| Famotidine | Famotidine | 147 | 49 |
| Lovastatin | Lovastatin | 146 | 40 |
| Methocarbamol | Methocarbamol | 143 | 26 |
| Jardiance | Empagliflozin | 141 | 15 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 140 | 38 |
| Tramadol Hcl | Tramadol Hcl | 139 | 44 |
| Doxycycline Hyclate | Doxycycline Hyclate | 138 | 107 |
| Prednisone | Prednisone | 137 | 39 |
| Citalopram Hbr | Citalopram Hydrobromide | 135 | 46 |
| Clonazepam | Clonazepam | 134 | 20 |
| Glimepiride | Glimepiride | 133 | 38 |
| Ondansetron Hcl | Ondansetron Hcl | 133 | 51 |
| Finasteride | Finasteride | 127 | 29 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 127 | 37 |
| Spironolactone | Spironolactone | 127 | 31 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 126 | 44 |
| Fluoxetine Hcl | Fluoxetine Hcl | 125 | 36 |
| Quetiapine Fumarate | Quetiapine Fumarate | 118 | 38 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 117 | 42 |
| Atenolol | Atenolol | 115 | 28 |
| Pregabalin | Pregabalin | 115 | 21 |
| Januvia | Sitagliptin Phosphate | 111 | 19 |
| Bupropion Xl | Bupropion Hcl | 109 | 35 |
| Ibuprofen | Ibuprofen | 108 | 37 |
| Metformin Hcl Er | Metformin Hcl | 106 | 32 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 106 | 59 |
| Amiodarone Hcl | Amiodarone Hcl | 105 | 25 |
| Clonidine Hcl | Clonidine Hcl | 105 | 31 |
| Ezetimibe | Ezetimibe | 104 | 23 |
| Pravastatin Sodium | Pravastatin Sodium | 102 | 21 |
| Ozempic | Semaglutide | 99 | 33 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 97 | 24 |
| Latanoprost | Latanoprost | 97 | 28 |
| Labetalol Hcl | Labetalol Hcl | 94 | 23 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 94 | 19 |
| Lorazepam | Lorazepam | 93 | 20 |
| Aripiprazole | Aripiprazole | 90 | 15 |
| Lamotrigine | Lamotrigine | 85 | 18 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 84 | 66 |
| Entresto | Sacubitril/Valsartan | 84 | 13 |
| Meclizine Hcl | Meclizine Hcl | 84 | 34 |
| Doxazosin Mesylate | Doxazosin Mesylate | 82 | 19 |
| Ropinirole Hcl | Ropinirole Hcl | 79 | 22 |
| Zolpidem Tartrate | Zolpidem Tartrate | 79 | 16 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 77 | 21 |
| Oxybutynin Chloride | Oxybutynin Chloride | 76 | 21 |
| Diclofenac Sodium | Diclofenac Sodium | 75 | 24 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 75 | 30 |
| Alendronate Sodium | Alendronate Sodium | 68 | 23 |
| Amitriptyline Hcl | Amitriptyline Hcl | 68 | 13 |
| Breo Ellipta | Fluticasone/Vilanterol | 68 | 13 |
| Glipizide | Glipizide | 68 | 11 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 67 | 14 |
| Chlorthalidone | Chlorthalidone | 66 | 23 |
| Colchicine | Colchicine | 66 | 21 |
| Warfarin Sodium | Warfarin Sodium | 66 | 15 |
| Torsemide | Torsemide | 64 | 16 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 63 | 14 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 62 | 18 |
| Bumetanide | Bumetanide | 61 | 17 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 61 | 16 |
| Synthroid | Levothyroxine Sodium | 61 | 18 |
| Estradiol | Estradiol | 60 | 21 |
| Olanzapine | Olanzapine | 60 | 11 |
| Metoclopramide Hcl | Metoclopramide Hcl | 57 | 14 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 57 | 16 |
| Amoxicillin | Amoxicillin | 56 | 41 |
| Diazepam | Diazepam | 56 | 16 |
| Primidone | Primidone | 56 | 12 |
| Topiramate | Topiramate | 56 | suppressed |
| Lactulose | Lactulose | 54 | 18 |
| Lokelma | Sodium Zirconium Cyclosilicate | 54 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 54 | 14 |
| Promethazine Hcl | Promethazine Hcl | 53 | 20 |
| Ceftriaxone | Ceftriaxone Sodium | 52 | 41 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 50 | 29 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 49 | 13 |
| Diltiazem 24hr Er | Diltiazem Hcl | 48 | suppressed |
| Fluconazole | Fluconazole | 48 | 31 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 46 | 29 |
| Propranolol Hcl | Propranolol Hcl | 46 | 11 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 45 | 12 |
| Mounjaro | Tirzepatide | 45 | suppressed |
| Nystatin | Nystatin | 45 | 18 |
| Myrbetriq | Mirabegron | 44 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 44 | 12 |
| Boostrix Tdap | Diphth,pertuss(Acell),tet Vac | 43 | 43 |
| Creon | Lipase/Protease/Amylase | 43 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 43 | 13 |
| Gemtesa | Vibegron | 42 | suppressed |
| Cephalexin | Cephalexin | 40 | 28 |
| Sucralfate | Sucralfate | 40 | 11 |
| Azelastine Hcl | Azelastine Hcl | 39 | 14 |
| Flecainide Acetate | Flecainide Acetate | 39 | suppressed |
| Hydrocortisone | Hydrocortisone | 38 | 15 |
| Acyclovir | Acyclovir | 37 | 19 |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 37 | suppressed |
| Verapamil Er | Verapamil Hcl | 37 | 11 |
| Bupropion Hcl Sr | Bupropion Hcl | 36 | 12 |
| Valacyclovir | Valacyclovir Hcl | 36 | 15 |
| Calcitriol | Calcitriol | 34 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl/Pf | 34 | 32 |
| Propranolol Hcl Er | Propranolol Hcl | 34 | suppressed |
| Ondansetron Odt | Ondansetron | 33 | 18 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 33 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 31 | suppressed |
| Levofloxacin | Levofloxacin | 31 | 21 |
| Naproxen | Naproxen | 31 | 13 |
| Oxcarbazepine | Oxcarbazepine | 31 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 31 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 30 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 30 | 13 |
| Benazepril Hcl | Benazepril Hcl | 29 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 29 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 29 | suppressed |
| Ingrezza | Valbenazine Tosylate | 29 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 29 | 21 |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 29 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 29 | suppressed |
| Cefdinir | Cefdinir | 27 | 23 |
| Minoxidil | Minoxidil | 27 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 26 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 26 | 11 |
| Midodrine Hcl | Midodrine Hcl | 26 | 17 |
| Nitroglycerin | Nitroglycerin | 26 | 21 |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 26 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 25 | suppressed |
| Carbamazepine | Carbamazepine | 25 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 25 | suppressed |
| Timolol Maleate | Timolol Maleate | 25 | suppressed |
| Verapamil Sr | Verapamil Hcl | 25 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 24 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 24 | suppressed |
| Valsartan | Valsartan | 24 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 23 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 23 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 23 | 12 |
| Azathioprine | Azathioprine | 22 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 22 | 21 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 22 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 22 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 22 | 19 |
| Aptiom | Eslicarbazepine Acetate | 21 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 21 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 21 | 14 |
| Dabigatran Etexilate | Dabigatran Etexilate Mesylate | 20 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 20 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 20 | suppressed |
| Diltiazem 12hr Er | Diltiazem Hcl | 20 | suppressed |
| Irbesartan | Irbesartan | 20 | suppressed |
| Klor-Con M20 | Potassium Chloride | 20 | suppressed |
| Ramipril | Ramipril | 20 | suppressed |
| Rybelsus | Semaglutide | 20 | suppressed |
| Sps | Sodium Polystyrene Sulfon/Sorb | 20 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 20 | suppressed |
| Amantadine | Amantadine Hcl | 19 | suppressed |
| Glipizide Er | Glipizide | 19 | suppressed |
| Metronidazole | Metronidazole | 19 | 12 |
| Silodosin | Silodosin | 19 | suppressed |
| Zonisamide | Zonisamide | 19 | suppressed |
| Indapamide | Indapamide | 18 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 18 | 18 |
| Solu-Medrol | Methylprednisolone Sod Succ/Pf | 18 | 18 |
| Symbicort | Budesonide/Formoterol Fumarate | 18 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 18 | 14 |
| Celecoxib | Celecoxib | 17 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 17 | suppressed |
| Levemir Flexpen | Insulin Detemir | 17 | suppressed |
| Movantik | Naloxegol Oxalate | 17 | suppressed |
| Rivastigmine | Rivastigmine | 17 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 17 | suppressed |
| Clotrimazole | Clotrimazole | 16 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 16 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 16 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 16 | 15 |
| Linzess | Linaclotide | 16 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 16 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 16 | suppressed |
| Vraylar | Cariprazine Hcl | 16 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 15 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 15 | suppressed |
| Chlordiazepoxide-Clidinium | Chlordiazepoxide/Clidinium Br | 15 | suppressed |
| Cinacalcet Hcl | Cinacalcet Hcl | 15 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 15 | suppressed |
| Desvenlafaxine Er | Desvenlafaxine | 15 | suppressed |
| Ketoconazole | Ketoconazole | 15 | suppressed |
| Ranolazine Er | Ranolazine | 15 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 14 | suppressed |
| Benzonatate | Benzonatate | 14 | 12 |
| Haloperidol | Haloperidol | 14 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 14 | suppressed |
| Lyumjev Kwikpen U-100 | Insulin Lispro-Aabc | 14 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 14 | suppressed |
| Methimazole | Methimazole | 14 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 14 | suppressed |
| Permethrin | Permethrin | 14 | suppressed |
| Phenytoin | Phenytoin | 14 | suppressed |
| Pradaxa | Dabigatran Etexilate Mesylate | 14 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 14 | suppressed |
| Veltassa | Patiromer Calcium Sorbitex | 14 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 14 | suppressed |
| Amlodipine-Olmesartan | Amlodipine Bes/Olmesartan Med | 13 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 13 | suppressed |
| Humira Pen | Adalimumab | 13 | suppressed |
| Mupirocin | Mupirocin | 13 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl/Pf | 13 | 13 |
| Pioglitazone Hcl | Pioglitazone Hcl | 13 | suppressed |
| Budesonide | Budesonide | 12 | suppressed |
| Diltiazem 24hr Er (Xr) | Diltiazem Hcl | 12 | suppressed |
| Febuxostat | Febuxostat | 12 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 12 | suppressed |
| Indomethacin | Indomethacin | 12 | suppressed |
| Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 12 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 12 | suppressed |
| Lansoprazole | Lansoprazole | 12 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 12 | suppressed |
| Lidocaine | Lidocaine | 12 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 12 | suppressed |
| Phenobarbital | Phenobarbital | 12 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 12 | suppressed |
| Temazepam | Temazepam | 12 | suppressed |
| Brilinta | Ticagrelor | 11 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 11 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 11 | suppressed |
| Daptomycin | Daptomycin | 11 | suppressed |
| Fenofibrate | Fenofibrate | 11 | suppressed |
| Fiasp | Insulin Aspart (Niacinamide) | 11 | suppressed |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 11 | suppressed |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 11 | suppressed |
| Nyamyc | Nystatin | 11 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 11 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 11 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 11 | suppressed |
| Telmisartan | Telmisartan | 11 | suppressed |
| Triumeq | Abacavir/Dolutegravir/Lamivudi | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $253.59 · 7 records | ABBVIE INC. | APTIMA, FREESTYLE LIBRE 3, QULIPTA, Wegovy | 7 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error